Enterovirus RNA in blood is linked to the development of type 1 diabetes

Diabetes

Volumn 60, Issue 1, 2011, Pages 276-279

  Oikarinen, Sami ^a   Martiskainen, Mika ^a   Tauriainen, Sisko ^a   Huhtala, Heini ^b   Ilonen, Jorma ^c,d   Veijola, Riitta ^e   Simell, Olli ^d   Knip, Mikael ^f,g   Hyöty, Heikki ^a,f  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

^e UNIVERSITY OF OULU   (Finland)

^f TAMPERE UNIVERSITY HOSPITAL   (Finland)

^g UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE DECARBOXYLASE ANTIBODY; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR2 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY; VIRUS RNA;

ARTICLE; BLOOD ANALYSIS; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; ENTEROVIRUS; ENTEROVIRUS INFECTION; FEMALE; GENETIC SUSCEPTIBILITY; GROUPS BY AGE; HAPLOTYPE; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NEWBORN; NONHUMAN; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; VIRUS DETECTION;

CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; ENTEROVIRUS; FEMALE; FINLAND; GENETIC PREDISPOSITION TO DISEASE; HLA ANTIGENS; HLA-DQ ANTIGENS; HUMANS; INFANT; INFANT, NEWBORN; INSULIN ANTIBODIES; INSULIN-SECRETING CELLS; MALE; PREDICTIVE VALUE OF TESTS; RNA, VIRAL;

EID: 78751502671     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db10-0186     Document Type: Article

References (25)

1. Cabrera-Rode E, Sarmiento L, Tiberti C, Molina G, Barrios J, Hernandez D, Diaz-Horta O, Di Mario U. Type 1 diabetes islet associated antibodies in subjects infected by echovirus 16. Diabetologia 2003;46:1348-1353
2. Wagenknecht LE, Roseman JM, Herman WH. Increased incidence of insulin-dependent diabetes mellitus following an epidemic of Coxsackievirus B5. Am J Epidemiol 1991;133:1024-1031
3. Tauriainen S, Oikarinen S, Oikarinen M, Hyoty H: Enteroviruses in the pathogenesis of type 1 diabetes. Semin Immunopathol
4. Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia, 2009
5. Oikarinen M, Tauriainen S, Honkanen T, Oikarinen S, Vuori K, Kaukinen K, Rantala I, Maki M, Hyoty H. Detection of enteroviruses in the intestine of type 1 diabetic patients. Clin Exp Immunol 2008;151:71-75
6. Tracy S, Drescher KM, Jackson JD, Kim K, Kono K. Enteroviruses, type 1 diabetes and hygiene: a complex relationship. Rev Med Virol 2010;20:106-116
7. Smyth DJ, Cooper JD, Bailey R, Field S, Burren O, Smink LJ, Guja C, Ionescu-Tirgoviste C, Widmer B, Dunger DB, Savage DA, Walker NM, Clayton DG, Todd JA. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 2006;38:617-619
8. Lonnrot M, Salminen K, Knip M, Savola K, Kulmala P, Leinikki P, Hyypia T, Akerblom HK, Hyoty H, the Childhood Diabetes in Finland (DiMe) Study Group. Enterovirus RNA in serum is a risk factor for beta-cell autoimmunity and clinical type 1 diabetes: a prospective study. J Med Virol 2000;61:214-220
9. Fuchtenbusch M, Irnstetter A, Jager G, Ziegler AG. No evidence for an association of Coxsackie virus infections during pregnancy and early childhood with development of islet autoantibodies in offspring of mothers or fathers with type 1 diabetes. J Autoimmun 2001;17:333-340
10. Graves PM, Rotbart HA, Nix WA, Pallansch MA, Erlich HA, Norris JM, Hoffman M, Eisenbarth GS, Rewers M. Prospective study of enteroviral infections and development of beta-cell autoimmunity: the Diabetes Autoimmunity Study in the Young (DAISY). Diabetes Res Clin Pract 2003;59: 51-61
11. Salminen K, Sadeharju K, Lonnrot M, Vahasalo P, Kupila A, Korhonen S, Ilonen J, Simell O, Knip M, Hyoty H. Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study. J Med Virol 2003;69:91-98
12. Nanto-Salonen K, Kupila A, Simell S, Siljander H, Salonsaari T, Hekkala A, Korhonen S, Erkkola R, Sipila JI, Haavisto L, Siltala M, Tuominen J, Hakalax J, Hyoty H, Ilonen J, Veijola R, Simell T, Knip M, Simell O. Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial. Lancet 2008;372:1746-1755
13. Hermann R, Turpeinen H, Laine AP, Veijola R, Knip M, Simell O, Sipila I, Akerblom HK, Ilonen J. HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families. Tissue Antigens 2003;62:162-169
14. Kukko M, Kimpimaki T, Korhonen S, Kupila A, Simell S, Veijola R, Simell T, Ilonen J, Simell O, Knip M. Dynamics of diabetes-associated autoantibodies in young children with human leukocyte antigen-conferred risk of type 1 diabetes recruited from the general population. J Clin Endocrinol Metab 2005;90:2712-2717
15. Lonnrot M, Sjoroos M, Salminen K, Maaronen M, Hyypia T, Hyoty H. Diagnosis of enterovirus and rhinovirus infections by RT-PCR and timeresolved fluorometry with lanthanide chelate labeled probes. J Med Virol 1999;59:378-384
16. Schulte BM, Bakkers J, Lanke KH, Melchers WJ, Westerlaken C, Allebes W, Aanstoot HJ, Bruining GJ, Adema GJ, Van Kuppeveld FJ, Galama JM. Detection of enterovirus RNA in peripheral blood mononuclear cells of type 1 diabetic patients beyond the stage of acute infection. Viral Immunol 23:99-104
17. Lonnrot M, Knip M, Marciulionyte D, Rahko J, Urbonaite B, Moore WP, Vilja P, Hyoty H. Enterovirus antibodies in relation to islet cell antibodies in two populations with high and low incidence of type 1 diabetes. Diabetes Care 1999;22:2086-2088
18. Viskari H, Ludvigsson J, Uibo R, Salur L, Marciulionyte D, Hermann R, Soltesz G, Fuchtenbusch M, Ziegler AG, Kondrashova A, Romanov A, Knip M, Hyoty H. Relationship between the incidence of type 1 diabetes and enterovirus infections in different European populations: results from the EPIVIR project. J Med Virol 2004;72:610-617
19. Salminen KK, Vuorinen T, Oikarinen S, Helminen M, Simell S, Knip M, Ilonen J, Simell O, Hyoty H. Isolation of enterovirus strains from children with preclinical type 1 diabetes. Diabet Med 2004;21:156-164
20. Hou J, Sheikh S, Martin DL, Chatterjee NK. Coxsackievirus B4 alters pancreatic glutamate decarboxylase expression in mice soon after infection. J Autoimmun 1993;6:529-542
21. Sadeharju K, Knip M, Virtanen SM, Savilahti E, Tauriainen S, Koskela P, Akerblom HK, Hyoty H. Maternal antibodies in breast milk protect the child from enterovirus infections. Pediatrics 2007;119:941-946
22. Chapman NM, Kim KS. Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. Curr Top Microbiol Immunol 2008;323:275-292
23. Yin H, Berg AK, Westman J, Hellerstrom C, Frisk G. Complete nucleotide sequence of a Coxsackievirus B-4 strain capable of establishing persistent infection in human pancreatic islet cells: effects on insulin release, proinsulin synthesis, and cell morphology. J Med Virol 2002;68:544-557
24. Dotta F, Censini S, van Halteren AG, Marselli L, Masini M, Dionisi S, Mosca F, Boggi U, Muda AO, Prato SD, Elliott JF, Covacci A, Rappuoli R, Roep BO, Marchetti P. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci U S A 2007;104:5115-5120
25. Oikarinen M, Tauriainen S, Honkanen T, Vuori K, Karhunen P, Vasama- Nolvi C, Oikarinen S, Verbeke C, Blair GE, Rantala I, Ilonen J, Simell O, Knip M, Hyoty H. Analysis of pancreas tissue in a child positive for islet cell antibodies. Diabetologia 2008;51:1796-1802